Why is GNLX Down Today?
About Genelux Corporation Common Stock
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, an...
Overall Confidence: 67%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: +0.2%
Market Comparison
🔔 Get GNLX Alerts
We'll notify you when GNLX's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
GNLX has moved more than 3.0% down on 45 occasions in the past year.
Frequently Asked Questions
Why is GNLX stock down today?
Options traders are heavily buying puts on GNLX, with 96% of volume in puts. This suggests bearish institutional positioning.
Is GNLX stock a buy or sell right now?
Based on current analysis, GNLX shows 67% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the GNLX stock price target?
GNLX is currently trading at $2.44. Based on today's momentum, the expected short-term range is $2.37 - $2.49. See long-term price prediction →
Will GNLX stock continue falling?
Our analysis shows a 45% probability that GNLX's move continues in the next 1-3 days. Key level to watch: $2.32 (support).
Is GNLX stock oversold or overbought?
GNLX's RSI (Relative Strength Index) is currently at 35.9. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for GNLX stock?
GNLX's 10-day momentum indicator is at -0.28. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is GNLX outperforming or underperforming the market?
GNLX (-3.17%) is currently significantly underperforming the market (-2.8% vs SPY). Today, the S&P 500 (SPY) is down -0.39%, and Nasdaq (QQQ) is up 0.18%.
What does MACD indicate for GNLX?
GNLX's MACD (-0.07) is currently below the signal line (-0.05), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 27.2) is strong.
Is GNLX in an uptrend or downtrend?
Based on moving average analysis, GNLX is in a bearish trend. The price ($2.44) is trading below both the 20-day SMA ($2.67) and 50-day SMA ($2.81). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis